1. Home
  2. EXLS vs RGEN Comparison

EXLS vs RGEN Comparison

Compare EXLS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXLS
  • RGEN
  • Stock Information
  • Founded
  • EXLS 1999
  • RGEN 1981
  • Country
  • EXLS United States
  • RGEN United States
  • Employees
  • EXLS N/A
  • RGEN N/A
  • Industry
  • EXLS Business Services
  • RGEN Medical/Dental Instruments
  • Sector
  • EXLS Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • EXLS Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • EXLS 7.0B
  • RGEN 8.0B
  • IPO Year
  • EXLS 2006
  • RGEN N/A
  • Fundamental
  • Price
  • EXLS $45.96
  • RGEN $128.01
  • Analyst Decision
  • EXLS Strong Buy
  • RGEN Buy
  • Analyst Count
  • EXLS 8
  • RGEN 12
  • Target Price
  • EXLS $49.00
  • RGEN $172.67
  • AVG Volume (30 Days)
  • EXLS 1.6M
  • RGEN 847.4K
  • Earning Date
  • EXLS 04-29-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • EXLS N/A
  • RGEN N/A
  • EPS Growth
  • EXLS 21.21
  • RGEN N/A
  • EPS
  • EXLS 1.32
  • RGEN N/A
  • Revenue
  • EXLS $1,902,884,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • EXLS $13.96
  • RGEN $13.93
  • Revenue Next Year
  • EXLS $11.46
  • RGEN $14.35
  • P/E Ratio
  • EXLS $35.48
  • RGEN N/A
  • Revenue Growth
  • EXLS 14.18
  • RGEN 4.88
  • 52 Week Low
  • EXLS $28.59
  • RGEN $102.97
  • 52 Week High
  • EXLS $52.43
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • EXLS 52.11
  • RGEN 45.14
  • Support Level
  • EXLS $45.04
  • RGEN $123.10
  • Resistance Level
  • EXLS $48.16
  • RGEN $135.47
  • Average True Range (ATR)
  • EXLS 1.49
  • RGEN 6.76
  • MACD
  • EXLS 0.14
  • RGEN -0.72
  • Stochastic Oscillator
  • EXLS 51.38
  • RGEN 20.37

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: